A Pixel Is Worth a Thousand Words
The Development of Ophthalmic Imaging and OCT
Bevacizumab vs Triamcinolone for Diabetic Macular Edema
Look before you leap
Clinical Trial Spotlight
The CATT trial
Coding Q&A
Update on extended ophthalmoscopy
Coding Q&A
CPT codes for retinal procedures are changed for 2008
Combination Treatments for CNV in AMD
Early reports show promising results with several combinations of therapies
Comorbid Conditions in Vitreoretinal Surgery
Awareness of existing health conditions improves surgical results
Face Off
NSAIDs for post-vitrectomy and scleral buckle cases
Glycemic Control a Possible Factor in DR Progression
A trend in lower rates in diabetic retinopathy may be indicative of better diabetes management
Guest Editorial
Reflections on a Unique Group of Physicians
Inflammation and Age-related Macular Degeneration
New research expands understanding of how inflammation and the complement system contribute to AMD disease progression
Is Scleral Buckling on the Endangered Species List?
Retinal specialist argues that PPV is making this procedure obsolete
IVTA to the Rescue?
Triamcinolone tested for ranibizumab failure
OCT Imaging: Advances Over the Past 5 Years and Beyond
Optical coherence technology has come a long way, and it continues to move forward
Point/Counterpoint
23-g vs. 25-g vitrectomy surgery
PrONTO Boosts Hope for Variable Dosing of Ranibizumab
OCT-guided therapy may reduce frequency of injections for some patients
Retinal Regeneration Study Shows Encouraging Early Results
Phase 1 trial demonstrates therapeutic benefit without damage to the targeted structure
By Rochelle Nataloni, contributing writer
Retisert Reimplantation Appears Safe and Effective
Similar control of inflammation seen, as from first procedure
Sterile Endophthalmitis After Intravitreal Triamcinolone
Inflammation following injections is not always a result of preservatives
Study Seeks to Prove Safety and Efficacy of 2.5-mg Bevacizumab
Higher dosing may offer trend toward improved VA, less frequent injections
Subspecialty News
Genentech defends its position on Avastin and compounding pharmacies and more
Subspecialty News
OPKO’s SiRNA drug for AMD shows promise and more
Treatments on the Horizon for AMD Highlighted at RPS
Research is going beyond anti-VEGF to novel approaches to wet and dry AMD
Triple Therapy for Wet AMD Shows Impressive Results
Dynamic disease requires complex approach
Upfront
From the editor-in-chief
Upfront
From the editor-in-chief
VEGF Trap Phase 2 Study Shows Efficacy, Safety
CLEAR-IT 2 Primary Endpoint Results Disclosed
What Lies Beyond VEGF in the Treatment of PDR and DME?
Highlights from the Annual Charles L. Schepens Lecture
Combination Instrument Enhances Patient Care
A Duke University physician describes his experience with multi-modality imaging
By SCOTT W. COUSINS, MD
Exploring How New Imaging Modalities Can Change Patient Care
By Jeffrey S. Heier, MD
The Next Step in OCT Technology
Spectral domain provides unprecedented views of the retina
By Peter K. Kaiser, MD
Utilizing a Multi-Modality Imaging Instrument
A panel of experts discusses capabilities, efficiency and applications